AVITA Medical, Inc. - Common Stock (RCEL)

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class
Equity / Common Stock
Shares outstanding
26,475,256
Number of holders
42
Total 13F shares, excl. options
4,946,087
Shares change
-1,561,858
Total reported value, excl. options
$23,495,067
Value change
-$8,902,015
Put/Call ratio
9.61%
Number of buys
19
Number of sells
-37
Price
$4.75

Significant Holders of AVITA Medical, Inc. - Common Stock (RCEL) as of Q2 2022

70 filings reported holding RCEL - AVITA Medical, Inc. - Common Stock as of Q2 2022.
AVITA Medical, Inc. - Common Stock (RCEL) has 42 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 4,946,087 shares of 26,475,256 outstanding shares and own 18.68% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (1,147,755 shares), PURA VIDA INVESTMENTS, LLC (741,875 shares), FARALLON CAPITAL MANAGEMENT LLC (580,000 shares), BlackRock Inc. (476,890 shares), RENAISSANCE TECHNOLOGIES LLC (327,280 shares), MILLENNIUM MANAGEMENT LLC (267,163 shares), GEODE CAPITAL MANAGEMENT, LLC (250,307 shares), AMERIPRISE FINANCIAL INC (153,957 shares), RTW INVESTMENTS, LP (106,667 shares), and Ergoteles LLC (101,963 shares).
This table shows the top 42 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.